APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING FOR PREDICTION OF CYP-MEDIATED DRUG-DRUG INTERACTIONS INVOLVING ETHINYLESTRADIOL.

被引：0
|
作者：
Ezuruike, U. [1 ]
Humphries, H. [1 ]
Dickins, M. [1 ]
Neuhoff, S. [1 ]
Gardner, I. [1 ]
Rowland-Yeo, K. [1 ]
机构：
[1] Simcyp Ltd, Sheffield, S Yorkshire, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-044
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling
    Kato, Motohiro
    Shitara, Yoshihisa
    Sato, Hitoshi
    Yoshisue, Kunihiro
    Hirano, Masaru
    Ikeda, Toshihiko
    Sugiyama, Yuichi
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (08) : 1891 - 1901
  • [2] The Quantitative Prediction of CYP-mediated Drug Interaction by Physiologically Based Pharmacokinetic Modeling
    Motohiro Kato
    Yoshihisa Shitara
    Hitoshi Sato
    Kunihiro Yoshisue
    Masaru Hirano
    Toshihiko Ikeda
    Yuichi Sugiyama
    [J]. Pharmaceutical Research, 2008, 25 : 1891 - 1901
  • [3] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING TO EVALUATE POTENTIAL CYP-MEDIATED DRUG-DRUG INTERACTIONS (DDI) WITH SELUMETINIB.
    Zhou, L.
    Cohen-Rabbie, S.
    Vishwanathan, K.
    Schalkwijk, S.
    Tomkinson, H.
    Al-Huniti, N.
    Zhou, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S92 - S93
  • [4] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin and Prediction of Transporter-Mediated Drug-Drug Interactions Involving Gemfibrozil
    Macwan, J. S.
    Lukacova, V.
    Fraczkiewicz, G.
    Bolger, M. B.
    Akhlaghi, F.
    Woltosz, W. S.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S39 - S39
  • [5] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Ruijuan Xu
    Weihong Ge
    Qing Jiang
    [J]. European Journal of Clinical Pharmacology, 2018, 74 : 755 - 765
  • [6] Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban
    Xu, Ruijuan
    Ge, Weihong
    Jiang, Qing
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (06) : 755 - 765
  • [7] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    [J]. CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [8] Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib
    Liang Ni
    Liang Zheng
    Yueyue Liu
    Wenwen Xu
    Yingjie Zhao
    Ling Wang
    Qian Zhang
    Wei Hu
    Xijing Chen
    [J]. Advances in Therapy, 2023, 40 : 4310 - 4320
  • [9] Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib
    Ni, Liang
    Zheng, Liang
    Liu, Yueyue
    Xu, Wenwen
    Zhao, Yingjie
    Wang, Ling
    Zhang, Qian
    Hu, Wei
    Chen, Xijing
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4310 - 4320
  • [10] Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling
    Posada, Maria M.
    Bacon, James A.
    Schneck, Karen B.
    Tirona, Rommel G.
    Kim, Richard B.
    Higgins, J. William
    Pak, Y. Anne
    Hall, Stephen D.
    Hillgren, Kathleen M.
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (03) : 325 - 334
12345